MAO inhibitor disrupts tumor growth pathway
Tag: prostate cancer
Being overweight may raise your risk for advanced prostate cancer
A new study links being overweight in middle age and later adulthood to a greater risk of advanced prostate cancer. Jeanine Genkinger, PhD, an epidemiologist at Columbia University Mailman School of Public Health, and colleagues published the study in Annals…
Testing with combined biopsy method improves prostate cancer diagnosis in NIH study
A method of testing for prostate cancer developed at the National Cancer Institute (NCI) leads to more accurate diagnosis and prediction of the course of the disease, according to a large study. This method, which combines systematic biopsy, the current…
PCORI Board approves $150 million to fund large-scale patient-centered clinical studies
Also approves $16.4 million for new studies on maternal depression, HIV prevention, prostate cancer and care transitions
Researchers Announce Progress in Developing an Accurate, Noninvasive Urine Test For Prostate Cancer
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals in the urine.
Omega-3 fats do not protect against cancer
Peer reviewed — Systematic review — Humans
Metabolic Pathway Can Be Effectively Targeted to Treat Prostate Cancer, Roswell Park Team Shows
A Roswell Park team has identified a new strategy for treating prostate cancer — the first to target metabolic processes uniquely important to prostate cancer.
More time between prostate cancer screenings could improve outcomes
A new study in JNCI: Journal of the National Cancer Institute , published by Oxford University Press, finds significant benefits to lengthening the amount of time between prostate cancer screenings for men. Prostate cancer is one of the most common…
Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer
In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that a testosterone-related genetic variant – HSD3B1(1245C) – is associated with more aggressive disease and shorter survival in men with metastatic prostate cancer.
Moffitt Researchers Say Multiple Drug Adaptive Therapy is Possible
In a new article published online ahead of print in Cancer Research, members of Moffitt’s Center of Excellence for Evolutionary Therapy present a case study of an adaptive treatment approach based on evolutionary principles in prostate cancer and suggest that these strategies may provide a path toward improved multidrug adaptive therapies.
Researchers validate link between genetic variant and poor outcomes in advanced prostate cancer
Cleveland Clinic-led findings lay the foundation for more personalized treatments
Researchers validate link between genetic variant and poor outcomes in advanced prostate cancer
Cleveland Clinic-led findings lay the foundation for more personalized treatments
ORNL researchers develop ‘multitasking’ AI tool to extract cancer data in record time
As the second-leading cause of death in the United States, cancer is a public health crisis that afflicts nearly one in two people during their lifetime. Cancer is also an oppressively complex disease. Hundreds of cancer types affecting more than…
ORNL researchers develop ‘multitasking’ AI tool to extract cancer data in record time
As the second-leading cause of death in the United States, cancer is a public health crisis that afflicts nearly one in two people during their lifetime. Cancer is also an oppressively complex disease. Hundreds of cancer types affecting more than…
PIONEER milestone – First two datasets uploaded into the PIONEER Big Data platform
In an important step forward the first datasets have been transferred into the PIONEER Big Data platform by PIONEER partner Erasmus University Medical Centre (MC). Through the application of Big Data and the analyses of real-world evidence PIONEER aims to…
Statins May Lower Mortality in High-Risk Prostate Cancer Patients
Statin use alone or with metformin is associated with lower prostate cancer mortality from all causes, among high-risk patients.
Statins may lower mortality in high-risk prostate cancer patients
Statin use alone or with metformin is associated with lower prostate cancer mortality from all causes, among high-risk patients.
NCCN 2020 Annual Conference: Celebrating 25 years of NCCN
Evolving practices and emerging debates in cancer care
Statins may lower mortality in high-risk prostate cancer patients
Statin use alone or with metformin is associated with lower prostate cancer mortality from all causes, among high-risk patients.
NCCN 2020 Annual Conference: Celebrating 25 years of NCCN
Evolving practices and emerging debates in cancer care
Global study maps cancer mutations in large catalogue
Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus University Hospital, and Rigshospitalet. The researchers have compiled…
Global study maps cancer mutations in large catalogue
Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus University Hospital, and Rigshospitalet. The researchers have compiled…
Building a Safer CAR-T Therapy
A Ludwig Cancer Research study has devised a new type of chimeric antigen-receptor (CAR) T cell—a family of promising immunotherapies for cancer—that can be switched on and off on demand.
UPenn scientists receive ACGT grant to accelerate CAR T-Cell clinical trial
Novel gene therapy approach to prostate cancer already seeing results in clinical trial and may have impact on other solid tumor cancers
UPenn scientists receive ACGT grant to accelerate CAR T-Cell clinical trial
Novel gene therapy approach to prostate cancer already seeing results in clinical trial and may have impact on other solid tumor cancers
NCRI welcomes Prostate Cancer Research Centre as new partner
The National Cancer Research Institute (NCRI) is pleased to announce that Prostate Cancer Research Centre (PCRC) have recently joined as a partner; PCRC joins 17 other NCRI partners which include cancer research charities and funding bodies
Bluestar Genomics’ breakthrough study highlights promising data for multi-cancer detection from a single blood draw
Novel enrichment technology indicates high performance for breast, lung, pancreatic, and prostate cancer — Data presented at PWMC 2020
NCRI welcomes Prostate Cancer Research Centre as new partner
The National Cancer Research Institute (NCRI) is pleased to announce that Prostate Cancer Research Centre (PCRC) have recently joined as a partner; PCRC joins 17 other NCRI partners which include cancer research charities and funding bodies
Bluestar Genomics’ breakthrough study highlights promising data for multi-cancer detection from a single blood draw
Novel enrichment technology indicates high performance for breast, lung, pancreatic, and prostate cancer — Data presented at PWMC 2020
Study Examines Prostate Cancer Treatment Decisions
The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for Localized Prostate Cancer) study, coordinated by Vanderbilt University Medical Center, is a multi-site research study conducting long-term followup on men who were diagnosed with localized prostate cancer between 2011 and 2012.
AI can jump-start radiation therapy for cancer patients
Artificial intelligence can help cancer patients start their radiation therapy sooner – and thereby decrease the odds of the cancer spreading – by instantly translating complex clinical data into an optimal plan of attack.
Study reveals similar survival of African-American and white men with prostate cancer in an equal-access health care system
Among men with prostate cancer who received care from the Veterans Affairs (VA) Health System, an equal-access health care system, African American men did not have more advanced disease at the time of diagnosis or die earlier than white men,…
Study reveals similar survival of African-American and white men with prostate cancer in an equal-access health care system
Among men with prostate cancer who received care from the Veterans Affairs (VA) Health System, an equal-access health care system, African American men did not have more advanced disease at the time of diagnosis or die earlier than white men,…
Patients suffer invasive treatments for harmless cancers
Australians are increasingly being diagnosed with cancers that will do them no harm if left undetected or untreated, exposing them to unnecessary surgeries and chemotherapy, says a new study published online today in the Medical Journal of Australia . The…
Policymakers join experts at the European Parliament for radioligand therapy report launch
The event, co- hosted by Tanja Fajon MEP (S&D, Slovenia) and Ewa Kopacz MEP (EPP, Poland) saw the launch of the policy report ‘Radioligand therapy: realising the potential of targeted cancer care’
Ben-Gurion University researchers slash pre-drug screening time from years to days
BEER-SHEVA…January 22, 2020 – Researchers at Ben-Gurion University of the Negev (BGU) and The Hebrew University of Jerusalem (HU) have developed a powerful tool that will streamline and accelerate the development of disease therapies, transforming a multi-year process into just…
Policymakers join experts at the European Parliament for radioligand therapy report launch
The event, co- hosted by Tanja Fajon MEP (S&D, Slovenia) and Ewa Kopacz MEP (EPP, Poland) saw the launch of the policy report ‘Radioligand therapy: realising the potential of targeted cancer care’
Ben-Gurion University researchers slash pre-drug screening time from years to days
BEER-SHEVA…January 22, 2020 – Researchers at Ben-Gurion University of the Negev (BGU) and The Hebrew University of Jerusalem (HU) have developed a powerful tool that will streamline and accelerate the development of disease therapies, transforming a multi-year process into just…
Policymakers join experts at the European Parliament for radioligand therapy report launch
The event, co- hosted by Tanja Fajon MEP (S&D, Slovenia) and Ewa Kopacz MEP (EPP, Poland) saw the launch of the policy report ‘Radioligand therapy: realising the potential of targeted cancer care’
Ben-Gurion University researchers slash pre-drug screening time from years to days
BEER-SHEVA…January 22, 2020 – Researchers at Ben-Gurion University of the Negev (BGU) and The Hebrew University of Jerusalem (HU) have developed a powerful tool that will streamline and accelerate the development of disease therapies, transforming a multi-year process into just…
Zika inhibits the proliferation of prostate cancer cells
Experiments performed by Brazilian scientists showed that Zika virus inhibits tumor cell proliferation even when inactivated by high temperature; the study was supported by FAPESP and published in Scientific Reports
The eighth edition of Topics in Anti-Cancer Research has been issued
This volume focuses mainly on the new approaches and challenges encountered in cancer stem cell therapy.
The eighth edition of Topics in Anti-Cancer Research has been issued
This volume focuses mainly on the new approaches and challenges encountered in cancer stem cell therapy.
Comparing cancer costs is challenging, despite new price transparency rules
CHAPEL HILL, N.C.-Comparison shopping for airfare, a TV or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA…
The eighth edition of Topics in Anti-Cancer Research has been issued
This volume focuses mainly on the new approaches and challenges encountered in cancer stem cell therapy.
Comparing cancer costs is challenging, despite new price transparency rules
CHAPEL HILL, N.C.-Comparison shopping for airfare, a TV or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA…
Comparing cancer costs is challenging, despite new price transparency rules
CHAPEL HILL, N.C.-Comparison shopping for airfare, a TV or a car can be straightforward online. The same cannot be said for checking what hospitals charge for a standard radiation treatment for prostate cancer, according to a report published in JAMA…
Unfruitful: Eating more produce will not cure, stop prostate cancer
Diets bolstered by more vegetables produced no extra protection from the increased micronutrients
Unfruitful: Eating more produce will not cure, stop prostate cancer
Diets bolstered by more vegetables produced no extra protection from the increased micronutrients
Elevated Leukemia Incidence Is Found in World Trade Center Rescue and Recovery Workers
Responders who worked at the World Trade Center site after the attacks on September 11, 2001, have an increased overall cancer incidence compared to the general population, particularly in thyroid cancer, prostate cancer, and, for the first time ever reported, leukemia, according to a Mount Sinai study published in JNCI Cancer Spectrum in January.